NanoString Technologies Analysis: $108M Raised
What is NanoString Technologies?
NanoString Technologies provides life science tools for translational research using digital molecular barcoding. The company's platforms enable spatial transcriptomics, proteomics, and multiomics analysis in FFPE and fresh frozen tissues. Key products include GeoMx DSP for spatial profiling and CosMx SMI for high-plex single-cell imaging. The AtoMx SIP platform offers cloud-based informatics for spatial biology.
Location
Seattle, United States
Employees
201-500
Founded
2003
Funding Status
Seed
Product Features & Capabilities
- GeoMx® Digital Spatial Profiler for spatial transcriptomics and proteomics
- CosMx™ Spatial Molecular Imager for high-plex single-cell imaging
- nCounter® Analysis System for gene expression profiling
- AtoMx® Spatial Informatics Platform for cloud-based spatial data analysis
Use Cases
Profile 570+ proteins and whole transcriptomes in FFPE tissue; Perform high-plex spatial transcriptomics with 1000-plex RNA panels; Analyze cellular interactions and biomarker discovery in archived tissue samples; Conduct single-cell spatial analysis with subcellular resolution; Generate organ atlases using spatial data from human tissues
Other Considerations
Acquired by Bruker Corporation in 2024; 7,000+ peer-reviewed publications; Used by Human Cell Atlas project; Validated in clinical trial samples with archival FFPE tissue; Supported by academic and research institutions globally
See something that needs updating? Suggest edits to this profile.